Clinical Trials Browser

Acetaminophen × 90 days × Clear all

NCT05876390 2026-04-16

IRACPoP

Enrolling by invitation

Breast Neoplasms, Pain, Postoperative

NCT06824467 2026-04-16

TroFuse-022

Phase 3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05088876 2026-04-13

ParOP

Phase 4 Terminated

Pain

NCT06009926 2026-04-13

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

Phase 2 Active not recruiting

Other neoplasmOther solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06992427 2026-04-07

HOPE

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06305754 2026-04-02

MK-2870-009

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06788912 2026-03-31

MK-3475-01E

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT04268498 2026-03-24

ADVANCE

Phase 2 Active not recruiting

Multiple Myeloma

NCT05319730 2026-03-20

MK-3475-06B

Phase 1/2 Recruiting

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Phase 1 Completed

15 enrolled 21 charts

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT02439034 2026-03-16

KETOCOL

Phase 2 Completed

GynecologicHead & Neck

Agnosia, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT06043323 2026-03-12

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular

NCT05896228 2026-03-11

Iber-KDd

Phase 2 Recruiting

Multiple Myeloma

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase 1/2 Completed

224 enrolled 15 charts

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT05597878 2026-03-06

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Phase 2/3 Suspended

Agnosia, Prostatic Neoplasms

NCT05051735 2026-02-25

PARASTOP

Phase 3 Completed

Cancer Pain, Neoplasms, Pain

NCT07197684 2026-02-19

Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery

Phase NA Not yet recruiting

Breast Neoplasms, Pain, Postoperative, Chronic Pain

NCT03913559 2026-02-12

Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07101445 2026-02-10

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Phase 4 Recruiting

Multiple Myeloma

NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Phase 2 Completed

34 enrolled 22 charts

Sarcoma, Alveolar Soft Part

NCT04681105 2026-01-28

Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies

Phase 1 Completed

LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Mastocytosis, Systemic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma